Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Bio-Techne Corp - Common Stock (NQ:TECH)

43.31 -1.43 (-3.19%)
Streaming Delayed Price Updated: 3:56 PM EDT, May 15, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Bio-Techne Corp - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
Explore the top gainers and losers within the S&P500 index in today's session. ↗
Via Chartmill
Exploring the top movers within the S&P500 index during today's session. ↗
Via Chartmill
News headline image
The 5 Most Interesting Analyst Questions From Bio-Techne’s Q1 Earnings Call
Bio-Techne’s first quarter was marked by a negative market reaction, with revenue coming in below Wall Street expectations. Management attributed the shortfa... 
Via StockStory
Topics Earnings
News headline image
Investment Firm Sells $12.2 Million Worth of Materials Stock, According to Latest SEC Filing ↗
Trex Company is a leading provider of composite decking and outdoor living products for residential and commercial markets. 
Via The Motley Fool
Topics Regulatory Compliance
Bio-Techne Corp (NASDAQ:TECH) Slides as Q3 Earnings and Revenue Miss Estimates ↗
Via Chartmill
News headline image
1 Cash-Producing Stock Worth Investigating and 2 We Turn Down
While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient... 
Via StockStory
What's going on in today's session: S&P500 gap up and gap down stocks ↗
Via Chartmill
News headline image
TECH Q1 Deep Dive: Biotech Weakness and Order Timing Drive Top-Line Miss
Life sciences company Bio-Techne (NASDAQ:TECH) missed Wall Street’s revenue expectations in Q1 CY2026, with sales falling 1.5% year on year to $311.4 million... 
Via StockStory
News headline image
Bio-Techne (TECH) Q3 2026 Earnings Transcript ↗
Bio-Techne (TECH) Q3 2026 Earnings Transcript 
Via The Motley Fool
News headline image
Bio-Techne (TECH) Q1 2025 Earnings Transcript ↗
Bio-Techne (TECH) Q1 2025 Earnings Transcript 
Via The Motley Fool
News headline image
Bio-Techne (TECH) Q4 2025 Earnings Transcript ↗
Bio-Techne (TECH) Q4 2025 Earnings Transcript 
Via The Motley Fool
Wednesday's session: top gainers and losers in the S&P500 index ↗
Via Chartmill
Exploring the top movers within the S&P500 index during today's session. ↗
Via Chartmill
News headline image
Bio-Techne (NASDAQ:TECH) Reports Sales Below Analyst Estimates In Q1 CY2026 Earnings
Life sciences company Bio-Techne (NASDAQ:TECH) fell short of the market’s revenue expectations in Q1 CY2026, with sales falling 1.5% year on year to $311.4 m... 
Via StockStory
News headline image
Bio-Techne (TECH) Reports Q1: Everything You Need To Know Ahead Of Earnings
Life sciences company Bio-Techne (NASDAQ:TECH) will be reporting results this Wednesday morning. Here’s what to look for. Bio-Techne beat analysts’ revenue e... 
Via StockStory
Topics Artificial Intelligence
These S&P500 stocks are moving in today's session ↗
Via Chartmill
What's going on in today's session: S&P500 movers ↗
Via Chartmill
Thursday's session: gap up and gap down stock in the S&P500 index ↗
Via Chartmill
News headline image
3 Small-Cap Stocks That Fall Short
Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in th... 
Via StockStory
News headline image
1 Profitable Stock to Target This Week and 2 We Brush Off
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today does... 
Via StockStory
News headline image
1 S&P 500 Stock to Own for Decades and 2 We Question
The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all ... 
Via StockStory
Topics Stocks
News headline image
Revvity, Bio-Techne, Corcept, Supernus Pharmaceuticals, and Phibro Animal Health Shares Skyrocket, What You Need To Know
What Happened? A number of stocks jumped in the afternoon session after the reopening of the Strait of Hormuz signaled a cooling of global logistics and ener... 
Via StockStory
Topics Economy
News headline image
CONMED, Bruker, Waters Corporation, Avantor, and Bio-Techne Stocks Trade Down, What You Need To Know
What Happened? A number of stocks fell in the afternoon session after major indices including the S&P 500 and Dow Jones Industrial Average fell sharply as in... 
Via StockStory
Topics Government Stocks
News headline image
Q4 Research Tools & Consumables Earnings: Bio-Techne (NASDAQ:TECH) Earns Top Marks
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking a... 
Via StockStory
Topics Economy
Exploring the top movers within the S&P500 index during today's session. ↗
Via Chartmill
Stay informed with the top movers within the S&P500 index on Monday. ↗
Via Chartmill
News headline image
Is Bio-Techne Stock a Buy, Sell, or Hold After a Wealth Manager Dumps Its Entire Stake? ↗
Bio-Techne develops specialized reagents and diagnostic solutions for global research and clinical markets in the life sciences sector. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
3 Cash-Producing Stocks with Open Questions
A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. Luc... 
Via StockStory
News headline image
Bio-Techne, Bruker, DexCom, STERIS, and Teleflex Shares Plummet, What You Need To Know
What Happened? A number of stocks fell in the afternoon session after the February jobs report revealed an unexpected contraction in employment, with the hea... 
Via StockStory
Topics Economy
News headline image
3 Reasons to Avoid TECH and 1 Stock to Buy Instead
Bio-Techne trades at $56.99 and has moved in lockstep with the market. Its shares have returned 7.7% over the last six months while the S&P 500 has gained 5.... 
Via StockStory
Topics Stocks Supply Chain
< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.